Cargando…
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
Lipid nanoparticles (LNPs) have recently emerged as one of the most advanced technologies for the highly efficient in vivo delivery of exogenous mRNA, particularly for COVID-19 vaccine delivery. LNPs comprise four different lipids: ionizable lipids, helper or neutral lipids, cholesterol, and lipids...
Autores principales: | Swetha, K., Kotla, Niranjan G., Tunki, Lakshmi, Jayaraj, Arya, Bhargava, Suresh K., Hu, Haitao, Bonam, Srinivasa Reddy, Kurapati, Rajendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059764/ https://www.ncbi.nlm.nih.gov/pubmed/36992242 http://dx.doi.org/10.3390/vaccines11030658 |
Ejemplares similares
-
Optimization of solid lipid nanoparticles prepared by a single emulsification-solvent evaporation method
por: Pooja, Deep, et al.
Publicado: (2015) -
Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2021) -
Recent Advances in Lipid Nanoparticles for Delivery of mRNA
por: Yang, Lei, et al.
Publicado: (2022) -
Recent Advances in Site-Specific Lipid Nanoparticles
for mRNA Delivery
por: Xu, Xiao, et al.
Publicado: (2023) -
THEME: “Vaccines and Vaccine Adjuvants/Immunomodulators for Infectious Diseases”
por: Retnakumar, Sruthi Vijaya, et al.
Publicado: (2023)